08.17.23
Hyperbiotics has launched PRO-IBS Support, a dual-action blend of Lactiplantibacillus plantarum 299v and a bioavailable Boswellia serrata extract. The combination was specifically designed to stabilize gut discomfort and dysfunction in patients with IBS, and provide relief from bloating, gas, and irregularity.
An estimated 10-15% of the adult population has IBS, according to the American College of Gastroenterology, but only five to seven percent receive a diagnosis. PRO-IBS Support has been formulated to provide IBS symptom relief and nurture a healthy gut microbiome.
Each capsule contains 30 billion CFUs of Lactiplantibacillus plantarum 299v, which is considered efficacious in over 65 clinical studies. The highly bioavailable lecithin-based Boswellia serrata extract is present at 125 mg per serving, and is standardized for phytoactives content. The product is free from major allergens, contains no artificial colors, flavors, sweeteners, unnecessary excipients, is suitable for vegans and vegetarians, is shelf-stable, and is non-GMO.
"With the prevalence of IBS and related conditions, we saw a critical need to introduce an affordable, science-backed solution for patients," said John P. Troup, PhD, chief science and education officer at Hyperbiotics. "By pairing clinically studied Lactiplantibacillus plantarum 299v with Boswellia serrata extract, we are able to offer a dual-action solution that provides more effective relief than standalone probiotics."
An estimated 10-15% of the adult population has IBS, according to the American College of Gastroenterology, but only five to seven percent receive a diagnosis. PRO-IBS Support has been formulated to provide IBS symptom relief and nurture a healthy gut microbiome.
Each capsule contains 30 billion CFUs of Lactiplantibacillus plantarum 299v, which is considered efficacious in over 65 clinical studies. The highly bioavailable lecithin-based Boswellia serrata extract is present at 125 mg per serving, and is standardized for phytoactives content. The product is free from major allergens, contains no artificial colors, flavors, sweeteners, unnecessary excipients, is suitable for vegans and vegetarians, is shelf-stable, and is non-GMO.
"With the prevalence of IBS and related conditions, we saw a critical need to introduce an affordable, science-backed solution for patients," said John P. Troup, PhD, chief science and education officer at Hyperbiotics. "By pairing clinically studied Lactiplantibacillus plantarum 299v with Boswellia serrata extract, we are able to offer a dual-action solution that provides more effective relief than standalone probiotics."
